Manshiu Leung

Title: **Manshiu Leung: Innovator in Pharmaceutical Science**

Introduction

Manshiu Leung is a notable inventor based in Daly City, California, renowned for his significant contributions to pharmaceutical innovations. With a remarkable portfolio of eight patents, he has made strides in developing combination dosage forms that enhance the delivery and efficacy of opioid and analgesic medications.

Latest Patents

Among his latest innovations, Manshiu Leung has patented a revolutionary combination dosage form that comprises a mu opioid receptor antagonist and an opioid agent. This invention presents a solid composition featuring the peripheral mu opioid antagonist axelopran and its sulfate variant in an immediate release formulation. This combination enables the incorporation of opioid analgesic agents, which can be in the form of extended release, sustained release, modified release, or controlled release. Additionally, the patent outlines the methods for preparing such innovative dosage forms, paving the way for improved patient treatment options in pain management.

Career Highlights

Manshiu Leung has played pivotal roles in various reputable companies such as XenoPort, Inc. and Theravance Biopharma R&D IP, LLC. His experiences in these organizations have fueled his inventive spirit and his dedication to enhancing pharmaceutical approaches.

Collaborations

Throughout his career, Manshiu has collaborated with knowledgeable professionals, including notable coworkers Venkat R. Thalladi and Shaoling Li. These collaborations have likely stimulated innovative ideas and contributed to the successful development of his patented technologies.

Conclusion

Manshiu Leung stands out as a visionary inventor whose work on combination dosage forms has the potential to reshape pain management therapies. With his extensive background in pharmaceuticals and a solid collection of patents, he exemplifies the spirit of innovation that drives advancements in medical science today.